Search results
Author(s):
Navdeep Tangri
Added:
9 months ago
ERA 23 - In this short video from ERA 23, we are joined by Dr Navdeep Tangri (Max Rady College of Medicine, Manitoba, CA) to discuss the findings from the REVEAL-CKD Trial.
REVEAL-CKD is a retrospective, multinational, non-interventional, observational study which aimed to investigate the prevalence and consequences of undiagnosed chronic kidney disease (CKD) in a cohort of 670000 participants.
…
View more
Author(s):
Giuseppe Galati
Added:
3 years ago
Dr Giuseppe Galati (San Raffaele Scientific Institute, Milan, IT) discusses the DAPA-CKD study that was presented at ESC 2020.
This study evaluated the effect of dapagliflozin on renal outcomes and cardiovascular mortality in patients with chronic kidney disease.
Recorded remotely from Milan, 2020.
Recording Editor: Natascha Wienand
Editor: Mirjam Boros
View more
Author(s):
Harriette Van Spall
Added:
3 years ago
Prof David Wheeler (University College London, London, UK), co-chief investigator of the DAPA-CKD study joined Dr Harriette Van Spall (McMaster University, Hamilton, CA) to discuss the results of the study.
The purpose of DAPA-CKD was to evaluate the effect of dapagliflozin on renal outcomes and cardiovascular mortality in patients with chronic kidney disease.
Recorded remotely from Hamilton…
View more
CVD in CKD: An Introduction
Author(s):
Hilary Warrens
,
Debasish Banerjee
,
Charles A Herzog
Added:
1 year ago
Article
Author(s):
Shelley Zieroth
,
,
Added:
2 years ago
Following the release at ESC 2021 of updated guidelines for the diagnosis and treatment of acute and chronic heart failure, Dr Shelley Zieroth (University of Manitoba, CA), Prof Hiddo L Heerspink (University Medical Center, Groningen, NL) andProf Kamlesh Khunti (University of Leicester, UK) discuss the implications for practice.
This three-part series, 'SGLT-2 Inhibitors and Cardio-renal…
View more
Author(s):
Zaki Akhtar
,
Lisa WM Leung
,
Christos Kontogiannis
,
et al
Added:
2 years ago
Author(s):
Konstantina Kipourou
,
Jamie M O’Driscoll
,
Rajan Sharma
Added:
2 years ago
Author(s):
Olivier Phan
,
Michel Burnier
,
Grégoire Wuerzner
Added:
3 years ago
Chronic kidney disease (CKD) is characterised by progressive nephron loss leading to increased intraglomerular pressure, glomerular permeability, proteinuria and systemic hypertension. The prevalence of CKD defined as estimated glomerular filtration rate (eGFR) of <60 mL/min per 1.73 m2 ranges from 2 to 12 % in Europe and in the US.1,2 CKD is an independent risk factor for the development of…
View more
Author(s):
David K Ryan
,
Debasish Banerjee
,
Fadi Jouhra
Added:
1 year ago
Author(s):
Gautam R Shroff
,
Michelle D Carlson
,
Roy O Mathew
Added:
2 years ago